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Abstract: Arthropod vectors control the replication of arboviruses through their innate antiviral
immune responses. In particular, the RNA interference (RNAi) pathways are of notable significance
for the control of viral infections. Although much has been done to understand the role of RNAi in
vector populations, little is known about its importance in non-vector mosquito species. In this study,
we investigated the presence of an RNAi response in Toxorhynchites amboinensis, which is a non-blood
feeding species proposed as a biological control agent against pest mosquitoes. Using a derived cell
line (TRA-171), we demonstrate that these mosquitoes possess a functional RNAi response that is
active against a mosquito-borne alphavirus, Semliki Forest virus. As observed in vector mosquito
species, small RNAs are produced that target viral sequences. The size and characteristics of these
small RNAs indicate that both the siRNA and piRNA pathways are induced in response to infection.
Taken together, this data suggests that Tx. amboinensis are able to control viral infections in a similar
way to natural arbovirus vector mosquito species. Understanding their ability to manage arboviral
infections will be advantageous when assessing these and similar species as biological control agents.
Keywords: RNA interference (RNAi); antiviral responses; Toxorhynchites amboinensis; alphavirus;
virus discovery
1. Introduction
Toxorhynchites (Diptera: Culicidae) mosquitoes or “elephant mosquitoes” are the largest mosquitoes
on the planet, with a wingspan surpassing 12 mm for some species [1]. Unlike most mosquito species,
they are autogenous and do not require a blood meal for egg production. Instead, all instars of larvae
are predatory against other mosquito larvae, including those of medical relevance, such as Aedes aegypti,
which is a key vector for many important human arboviruses. As a result, various species, such as
Tx. splendens, Tx. rutilus, and Tx. amboinensis, have been proposed as biological control agents against
pest species [2–4].
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As a consequence of adult Toxorhynchites being exclusively nectarivorous, they are not considered
to be natural vectors for arboviruses. However, previous work has demonstrated that several species
of Toxorhynchites are susceptible to important arboviruses and, as such, have a role as artificial hosts
for their detection and propagation. Tx. amboinensis, Tx. brevipalpis, Tx. rutilus rutilus, Tx. theobaldi,
and Tx. splendens have previously been shown to be susceptible to a number of flaviviruses including
dengue virus (DENV) serotypes 1–4, Japanese encephalitis virus (JEV), yellow fever virus (YFV),
and Zika virus (ZIKV) [5–7]. Furthermore, certain species have also demonstrated the capacity for
generating greater viral titers, especially each of the four DENV serotypes, compared to vector
species or mammalian cells commonly used to produce virus. For instance, Tx. amboinensis and
Tx. brevipalpis generate greater titers of DENV compared to Ae. albopictus or their derived cell line,
C6/36 [5,8]. Tx. amboinensis were also shown to be susceptible to JEV and allowed it to replicate to high
titres [5]. In addition to DENV and other flaviviruses, Tx. amboinensis have been shown to efficiently
propagate alphaviruses (chikungunya (CHIKV), Ross River (RRV), and Venezuelan equine encephalitis
(VEEV) viruses) and bunyaviruses (La Crosse (LACV), San Angelo (SAV), and Keystone (KEYV))
viruses [5,9,10].
Several continuous cell lines have been derived from Toxorhynchites to facilitate virus propagation
and isolation in vitro. Cell cultures derived from Tx. amboinensis have been established which show
comparative levels of sensitivity as the adults and commonly used vector cell lines to DENV and
other arboviruses [11–14]. These cultures provide a useful in vitro system for the study of interactions
between arboviruses and Toxorhynchites mosquitoes.
Despite their usability for the propagation of arboviruses, nothing is known about the antiviral
responses in this mosquito genus. In nature, Toxorhynchites spp. may become exposed to arboviruses
by predating on vertically infected larvae [15], and it is therefore valuable to understand their antiviral
capabilities when considering their use as an alternative to chemical pesticides against vector species.
Historically, much of our understanding of mosquito immunity came from extensive research carried
out in the Drosophila melanogaster model, although an increasingly detailed picture of mosquito
immunity in vector species is now emerging which highlights a number of key differences [16–21].
The major antiviral mechanism for the control of arboviral infections in mosquitoes is RNA interference
(RNAi), which is divided into several pathways differentiated by their effector proteins, small RNA
molecules, and their method of induction. The exogenous small interfering RNA (exo-siRNA), and to
a lesser extent, the PIWI-interacting RNA (piRNA) pathways are highly important in the context
of a viral infection [22–39]. The exo-siRNA pathway detects the production of virus-derived long
double-stranded RNA (dsRNA). These dsRNAs are cleaved into 21 nucleotide (nt) long virus-specific
siRNAs (vsiRNAs) by the exoribonuclease, Dicer 2 (Dcr2). The vsiRNAs are transferred to the
RNA-induced silencing complex (RISC) and loaded into the effector protein, Argonaute 2 (Ago2).
While one strand of the vsiRNA duplex is degraded, Ago2 uses the other strand to recognize
complementary viral RNA, which leads to the cleavage and degradation of the target sequence.
The piRNA pathway is not as well-characterized and it’s antiviral role(s) are less clear [40]. It also
differs considerably in mosquitoes compared to D. melanogaster [41]. In D. melanogaster, the pathway
involves PIWI proteins Piwi, Aub, and Ago3. However, Ae. aegypti lack orthologues of Aub and
Piwi, but express Ago3 and an additional 7 PIWI family proteins, Piwi1-7 [41]. The pathway involves
piRNA molecules, which are between 24–29 nt in length and are generated through a “ping-pong”
amplification system. Intermediate piRNAs are initially produced against genomic transposons and
display a characteristic uridine as the first nucleotide (U1). These are loaded into the Piwi complex
and are further processed to produce mature piRNAs with an adenine at the 10th nucleotide position
(A10). The mature piRNAs are bound by Ago3 and target complementary antisense RNA transcripts
to produce more piRNAs. Therefore, a typical characteristic of ping-pong derived piRNAs is not only
the A10 and U1 bias but also a high frequency of 10 nt complementarity to opposing small RNAs.
In this study, we describe an active antiviral immune response in Tx. amboinensis-derived TRA-171
cells. Our observations indicate that these cells possess a functional RNAi response that is effective
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against Semliki Forest virus (SFV, Togaviridae, Alphavirus) infection. We used deep sequencing analysis
to show the production of both vsiRNAs and virus-specific piRNAs derived from SFV. In addition,
silencing assays showed that RNAi responses are induced by the presence of sequence-specific dsRNA
against both viral RNAs and mRNAs transcribed from transfected plasmid DNA. This evidence
suggests that Tx. amboinensis is able to mount a classical RNAi immune response against viral infections
in a similar manner to what is known for mosquito vector species.
2. Materials and Methods
2.1. Cell Lines
Tx. amboinensis-derived TRA-171 cells (European Collection of Authenticated Cell Cultures
(ECACC), 90120514) were grown in media prepared in house consisting of L-15 (Leibovitz)
growth culture medium (Life Technologies, Carlsbad, CA, USA) mixed 1:1 with Mitsuhashi and
Maramorosch basal media prepared in house (CaCl22H2O (250 mg/lt), MgCl26H2O (125 mg/lt),
KCl (250 mg/lt), NaHCO3 (150 mg/lt), NaCl (8750 mg/lt), NaH2PO4H2O (250 mg/lt), D-glucose
(500 mg/lt), lactalbumin hydrolysate (8125 mg/lt), and yeastolate (0.75 mL/lt)) supplemented with
10% tryptose phosphate broth (TPB, Life Technologies), 10% fetal bovine serum (FBS, Life Technologies),
0.05% bovine serum albumin (BSA) (Sigma-Aldrich, St. Louis, MO, USA), 1% non-essential amino
acids (Sigma-Aldrich), and penicillin-streptomycin (final concentration 100 units/mL, 100 µg/mL
respectively, Life Technologies). D. melanogaster-derived S2 cells [38,42] were cultured in Schneider’s
growth media supplemented with 10% FBS and penicillin-streptomycin (final concentration
100 units/mL, 100 µg/mL, respectively). TRA-171 and S2 cells were maintained at 28 ˝C with
no additional CO2. Baby hamster kidney (BHK-21) [43] cells were grown in Glasgow’s minimal
essential medium (GMEM, Life Technologies) supplemented with 10% TPB, 10% newborn calf serum
(NBCS, Life Technologies), and penicillin-streptomycin (final concentration 100 units/mL, 100 µg/mL,
respectively) at 37 ˝C with 5% CO2.
2.2. Viruses
The prototype molecular clone of SFV, SFV4, and two derived reporter viruses either expressing
Firefly luciferase (FFLuc) (SFV4(3H)-FFLuc) or Renilla luciferase (RLuc) (SFV4(3H)-RLuc) inserted
between duplicated nsP2 cleavage sites at the nsP3/4 junction, were grown and titered by plaque assay
in BHK-21 cells, as described previously [24]. Infections were performed for 1 h at 28 ˝C by diluting
virus stocks in the appropriate volume of PBSA (phosphate buffered saline with 0.75% BSA) before
removing the inoculum and applying fresh growth media.
2.3. Plasmids
The FFLuc and RLuc luciferase expression plasmids, pIZ-Fluc and pAcIE1-Rluc, have been
previously described [37,38,44,45].
2.4. In Vitro Transcription of dsRNA
dsRNA molecules against either FFLuc or RLuc were produced using a T7 RNA polymerase
in vitro transcription kit (Megascript RNAi kit, Ambion, Foster City, CA, USA) using a PCR product
template flanked by T7 RNA polymerase promoter sequences. pIZ-Fluc [45] and pRL-CMV (Promega,
Madison, WI, USA) were used as a template for the amplification of dsRNAs targeting FFLuc and
RLuc, respectively. An eGFP-derived dsRNA was taken as a control. This sequence was obtained
from a gel-purified PCR product using peGFP-C1 (Clontech, Mountain View, CA, USA) as a template.
Primer sequences can be found in Table S1.
Internally radio-labelled dsRNAs were prepared by combining 5 µL 114 nt eGFP PCR product with
T7 polymerase sites, 4 µL 5ˆ Transcription buffer (Ambion), 2 µL DTT (0.1 M, Invitrogen, Carlsbad,
CA, USA), 1 µL rNTPs (10 mM each ATP, GTP and UTP with 0.1 mM CTP) (Promega), 3 µL α-32P
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rCTP (Perkin Elmer, Waltham, MA, USA), 1 µL T7 RNA polymerase (Ambion), 1 µL RNase inhibitor
(Invitrogen), and 3 µL RNase/DNase free H2O. The reaction was incubated for 1 to 3 h at 37 ˝C before
heating to 65 ˝C for 5 min and allowing it to gradually cool to room temperature. Following this, 2 µL
of DNase I and 1 µL of RNase A were added and the reaction was incubated for a further 30 min at
37 ˝C. The dsRNA could then be purified by running on an 8% native acrylamide gel.
2.5. Nucleic Acid Transfection
Cells were seeded at a density of 2.2ˆ 105 cells per well of a 24-well plate 24 h prior to transfection
with Dharmafect 2 (GE Healthcare, Chicago, IL, USA) following the manufacturer’s instructions.
For plasmid transfection experiments, each well was co-transfected with 100 ng pIZ-Fluc, 100 ng
pAcIE1-Rluc (as an internal control) with either 1 ng of dsRNA (FFLuc-specific or eGFP control dsRNA),
or 2 ng siRNAs (FFLuc-specific or Hygromycin B resistance gene control siRNA [39]). Cells were lysed
24 h post transfection (p.t.) and luciferase activity determined.
For infection experiments, viral reporter gene transcripts were silenced by transfecting 50 ng RLuc
or eGFP-specific control dsRNA. After 24 h, cells were infected with SFV4(3H)-RLuc at a multiplicity
of infection (MOI) of 0.005. Cells were lysed 24 h post infection (p.i.) and luciferase activities
were determined.
2.6. Luciferase Assay
The cells were lysed in Passive Lysis Buffer (Promega) and luciferase expression was determined
with either the Renilla-Glo Luciferase assay system (Promega) or the Dual Luciferase assay system
(Promega) and a GloMax luminometer.
2.7. Small RNA Sequencing and Analysis
The cells were grown at a density of 9 ˆ 105 per well of a six-well plate. RNA extraction was
performed using 1 mL TRIzol (Life Technologies) as per the manufacturer’s instructions, with the
addition of glycogen as a carrier. DNA libraries consisting of small RNAs between 15–40 nt were
gel purified and sequenced using the Illumina Hiseq 4000 platform at BGI Tech (Shenzhen, China).
Data analysis was carried out as described previously by aligning sequence reads to the SFV4 reference
genome (Genbank accession number: KP699763) [24,37]. A maximum of one mismatch or indel was
allowed in the alignments. Alignment lengths between 18–36 nt were selected for further analysis.
These were separated into two groups according to their orientation, i.e., if they mapped to the
genome (positive) or antigenome (negative). Coverage plots of mapped reads were generated using R
programming language. Sequence logos were generated using a Bioconductor package, motifStack [46].
The mapping positions of each small RNA that aligned to the positive strand of the SFV4 genome
was compared to the positions of small RNAs that aligned to the negative strand (antigenome).
Any overlaps between these were recorded. Similarly, small RNA pairs of 25–29 nt were compared
and their overlapping nucleotide frequencies were aggregated [47]. Using python program coding
and the R statistical package, standard scores (z-scores) of the overlapping nucleotides and their
frequencies were calculated and plotted. Small RNA sequencing data is available at Sequence Read
Archive (https://www.ncbi.nlm.nih.gov/sra) under the accession number: PRJNA486770.
2.8. In Vitro Dicer Cleavage Assay
TRA-171 and S2 cells were seeded at 9 ˆ 105 and 1 ˆ 106 cells per well of a six-well plate
respectively. Following a 24 h incubation, the media was removed. The cells were re-suspended in
sterile PBS and centrifuged for 5 min at 1500 rpm. The supernatant was removed and the procedure
repeated a second time as described. Following this, the pellet was re-suspended in 200 µL 1ˆ lysis
buffer (10 mM MgAc (Sigma-Aldrich) and 150 mM Hepes-KOH (pH 7.5)) and homogenized using
a micro-pestle. A further centrifugation step (14,000 rpm for 20 min at 4 ˝C) was performed to remove
cell debris, after which 5 µL of the supernatant was transferred to a fresh tube. To this was added,
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3 µL 32P labelled dsRNA, 1 µL H2O, and a 3 µL creatine mix (consisting of 1 µL DTT (1 M), 10 µL
creatine phosphate (12 mg/100 µL) (Calbiochem, San Diego, CA, USA), 20 µL 5ˆ lysis buffer (10 mM
MgAc and 150 mM Hepes-KOH (pH 7.5)), 20 µL glycerol, 2 µL RNase Inhibitor (Promega), 2 µL ATP
(100 mM) (Thermo Fisher Scientific, Waltham, MA, USA), 0.3 µL 20 mg/mL creatine phosphate kinase
in 1ˆ storage buffer (40 mg/mL lyophilized creatine kinase (Calbiochem) in 2ˆ storage buffer (ice-cold
40 mM tris-acetate (pH 6.8), 200 mM KAc, 0.2 mM EDTA, 20 mM β-mercaptoethanol) diluted 1:1 in
an equal volume of 100% ice-cold glycerol), and 4.7 µL RNase/DNase free H2O). The reactions were
incubated at 28 ˝C overnight. Subsequently, 200 µL 2ˆ PK buffer (200 mM Tris (pH 7.5), 300 mM NaCl,
5 mM EDTA, 2% SDS), 1 µL glycogen (10 mg/mL) (Roche, Basel, Switzerland), and 0.3 µL proteinase
K (10 mg/mL) (Sigma-Aldrich) were added and each reaction was incubated for a further 10 min
at 65 ˝C. Following this, 200 µL phenol/chloroform/isoamylalcohol (25:24:1) (Ambion) was added.
Reactions were vortexed for 15 sec and centrifuged for 10 min at 10,000 rpm. The aqueous phase was
transferred to a new tube containing 450 µL ice-cold 96% EtOH and centrifuged at 13,000 rpm for 10 min.
The supernatant was removed and the pellet washed with 400 µL ice cold 70% EtOH. The samples
were further centrifuged as described and the supernatant was removed. The resulting pellets were air
dried for 5–10 min prior to resuspension in 15 µL 2ˆ RNA gel loading buffer (Thermo Fisher Scientific).
The samples were boiled for 5 min at 65 ˝C before placing on ice for 2 min. On completion, the samples
were loaded onto a 0.75 mm 12% denaturing acrylamide gel with 0.96% urea chilled by submerging
the tank in ice-cold water. Electrophoresis was carried out at 200 V. The gel was then transferred to
a gel dryer and allowed to dry at 80 ˝C for 2 h. The resulting bands were detected by exposing the
gel to a phosphor imaging screen for ě16 h and viewed using a personal molecular imager (Bio-Rad,
Hercules, CA, USA).
2.9. Statistical Analysis
Statistical analysis was performed using GraphPad Prism. Data was analyzed using an unpaired,
two-tailed t-test.
2.10. Data Availability
Source data for the figures can be found at http://dx.doi.org/10.5525/gla.researchdata.703.
Small RNA sequencing data can be found under the accession number described above.
3. Results
3.1. SFV Infects Tx. amboinensis-Derived TRA-171 Cells
Tx. amboinensis-derived TRA-171 cells are known to be permissive to infection by CHIKV [14],
but it has not been shown that they can be infected by SFV, a related alphavirus. To answer this question,
TRA-171 cells were infected with SFV expressing luciferase (either RLuc or FFLuc) (Figure 1A), which
allows replication to be monitored directly. Cells were infected with SFV4(3H)-RLuc at a high (10) or
low (0.01) MOI and incubated for 24 h prior to lysing. As anticipated, proportional SFV replication
was detected at each MOI used (Figure 1B). To understand virus kinetics during infection, the cells
were infected with a second SFV reporter strain (SFV4(3H)-FFLuc) at MOI 10 and its replication
efficiency was monitored at regular intervals over 120 h. Both viral titres (Figure 1C) and luciferase
expression (Figure 1D) peaked after 48 h p.i. before decreasing. It was also determined that cell
numbers between infected and uninfected cultures were similar and increased at a comparable rate
over the 120 h observation period (Figure 1E). These observations are consistent with previous studies
that show a similar pattern of SFV infection in Ae. albopictus-derived cell lines [48,49]. This data
therefore suggests that SFV infection in the TRA-171 cell line displays similar kinetics to an arboviral
infection in vector cells.
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Figure 1. Infection of TRA-171 cells with SFV. (A) Schematic representation of the design of the reporter
strains of SFV expressing luciferase (Luc: either RLuc, SFV4(3H)-RLuc, or FFLuc, SFV4(3H)-FFLuc)
inserted between duplicated nsP2-protease cleavage sites at the nsP3/4 junction. (B) TRA-171 cells
were either mock infected or infected with SFV4(3H)-RLuc at MOI 10 or 0.01. Luciferase expression
was determined at 24 h p.i. by luciferase assay and relative luciferase activity was normalized against
background, shown on the Y-axis. (C) TRA-171 cells were infected with SFV4(3H)-FFLuc at MOI
10. Cell growth media was collected and replaced with fresh media at the given time points. Virus
production was determined by plaque assay and the titre was measured in plaque forming units
(PFU/mL). (D) The cells were infected as in (C) and lysed at the given time points to monitor viral
replication. Luciferase expression was determined by luciferase assay and relative luciferase units
are shown on the Y-axis. (E) The cells were either infected as in (C) (‚) or mock infected (‚) and cell
numbers were counted at the given time points. Mean values with standard error are shown for three
(B) or two (C–E) independent experiments conducted in triplicate. The analysis used the average of
each triplicate per experiment.
3.2. Functional RNAi Pathways are Present in TRA-171 Cells
A distinguishing feature of the exo-siRNA pathway in vector mosquitoes is that, through
Dcr2 cleavage of dsRNA, it produces 21 nt siRNAs th t are complementary to the target sequence.
To investigate if TRA-171 cells express a functional Dice enzyme and are thereby capable of generating
siRNAs, we used an in vitro Dic r cleavage assay. The cell extracts were incu ated with 32P i ternally
radio-labeled dsRNA and incubated overnight before isola ing the small RNAs. Extracts w e run
on an crylamide gel alongside size ma kers; input d RNA (114 nt) nd siRNAs (21 nt), as well as
extract from S2 cells as a positive control. Bo h samples showed the detection of input dsRNA i
addition to discernible band at the size expected for 21 nt siRNAs (Figure 2, Figure S1). This data
suggests that TRA-171 cells possess an active dicing enzyme that is effectively abl to cleave long
dsRNA molecules into small RNA of approximately the exp c ed s ze or s RNAs.
Viruses 2018, 10, 694 7 of 15
Viruses 2018, 10, x FOR PEER REVIEW  7 of 15 
 
 
Figure 2. Production of small RNAs from long dsRNA. The cellular extracts were prepared from TRA-
171 and S2 cells. The extracts were incubated with 32P internally-labeled dsRNA (114 nt). Size markers 
of long dsRNA (114 nt) and siRNAs (21 nt) are indicated to show approximate sizes. The image shown 
is representative of three independent experiments and shows relevant individual lanes. The 
complete image is shown in Supplementary Figure S1. 
The siRNA pathway is induced in a sequence specific manner through the detection of dsRNAs 
by Dcr2. To determine the ability of TRA-171 cells to silence a FFLuc reporter gene via the RNAi 
pathway, we performed a previously described reporter RNAi assay [50]. Cells were co-transfected 
with both pIZ-Fluc and pAcIE1-Rluc (as an internal control), as well as either FFLuc-specific or 
negative control dsRNA/siRNAs. Each condition was lysed 24 h p.t. and luciferase expression 
assessed. Our data demonstrates that the cells that received either FFLuc-specific dsRNAs (Figure 3A) 
or siRNAs (Figure 3B) showed a significant decrease in relative luciferase activity compared to the 
cells treated with control dsRNA/siRNAs. This suggests that TRA-171 cells are able to induce a gene 
silencing response, which is mediated by the presence of both sequence-specific dsRNA and siRNAs. 
 
 
Figure 3. dsRNA or siRNA mediated gene silencing in TRA-171 cells. The cells were co-transfected 
with pIZ-Fluc and pAcIE1-Rluc (as an internal control) alongside either dsRNA (A) or siRNAs (B) 
targeting FFLuc or a control. Luciferase expression was determined by luciferase assay 24 h p.t. and 
relative luciferase activity (FFLuc/RLuc) is shown on the Y-axis. Mean values with standard error are 
shown for four independent experiments performed in triplicate. The analysis used the average of 
each triplicate per experiment. * indicates significance, p < 0.05 by Student t-test. 
i r . Production of small RNAs from long dsRNA. The cellular extracts were prepared from
TRA-171 and S2 cells. The extracts were incubated with 32P internally-labeled dsRNA (114 nt).
Size markers of long dsRNA (114 nt) and siRNAs (21 nt) are indicated to show approximate sizes.
The image shown is representative of three independent experiments and shows relevant individual
lanes. The complete image is shown in Supplementary Figure S1.
The siRNA pathway is induced in a sequence specific manner through the detection of dsRNAs
by Dcr2. To determine the ability of TRA-171 cells to silence a FFLuc reporter gene via the RNAi
pathway, we performed a previously described reporter RNAi assay [50]. Cells were co-transfected
with both pIZ-Fluc and pAcIE1-Rluc (as an internal control), as well as either FFLuc-specific or negative
control dsRNA/siRNAs. Each condition was lysed 24 h p.t. and luciferase expression assessed.
Our data demonstrates that the cells that received either FFLuc-specific dsRNAs (Figure 3A) or siRNAs
(Figure 3B) showed a significant decrease in relative luciferase activity compared to the cells treated
with control dsRNA/siRNAs. This suggests that TRA-171 cells are able to induce a gene silencing
response, which is mediated by the presence of both sequence-specific dsRNA and siRNAs.
3.3. An Active dsRNA-Inducible RNAi Response has Antiviral Activity against SFV Infection in
TRA-171 Cells
Next, we assessed if this silencing pathway has an inducible antiviral function against SFV.
The cells were first treated with either RLuc-specific or eGFP-specific control dsRNA prior to infection
with SFV4(3H)-RLuc. The infections were performed at either a high (10) or low (0.005) MOI. The cells
were lysed 24 h p.i. and luciferase expression was assessed. A decrease in the relative luciferase
activity was observed in cells treated with RLuc-specific dsRNA when compared to those that received
control eGFP-specific dsRNA at both MOIs, which directly indicates a decrease in viral replication and,
therefore, a reduction in virus production (Figure 4A,B). These findings suggest that TRA-171 cells
possess a sequence specific antiviral response that can be externally induced by dsRNA.
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with dsRNA against either RLuc or eGFP (as a control) 24 h prior to being either mock infected or
infected with SFV(3H)-RLuc at MOI 10 (A) or 0.005 (B). Luciferase expression was determined by
luciferase assay 24 h p.i. and luciferase activity is shown on the Y-axis. Mean values with standard
error are shown for three independent experiments performed in triplicate. The analysis used the
average of each triplicate per experiment. * indicates significance, p < 0.05 by Student t-test.
3.4. SFV Infection Induces Small RNA Production in TRA-171 Cells
It has previously been shown that, following infection, non-vector mosquito cells are capable of
generating small RNAs of the expected size and properties expected of vsiRNAs and vpiRNAs [22,50].
Having shown that TRA-171 cells have an inducible RN i response that is capable of controlling
SFV replication, we next wanted to establish if TRA-171 cells have the capacity to generate vsiRNAs
and/or vpiRNAs which specifically target SFV. TRA-171 cells were infected with SFV4 at MOI 10 and
RNA isolated 24 h p.i. for s quencing. Small RNAs were sequ nced and analyzed by mapping to
both the SFV geno e and the antigenome (Figure 5, Supplementary Table S2). SFV-specific vsiRNAs
predominantly 21 nt in length were found to be produced within infected cells (Figure 5A). These reads
were found to map to both the viral genome and th antigenome in ap roximately equal quantities.
The pattern of vsiRNA distribution observed (Figure 5B) indicates regions of many reads (hot spots)
and regions with few reads (cold spots). A second class of SFV-specific small RNAs were also identified,
which ranged fro 24–29 nt and again mapped to both the genome and antigenome f SFV (Figure 5A).
These preferentially targeted specific regions of the coding strand (Figure 5C) and presented with
the characteristic signature of piRNAs; a bias for A at position 10 and a U at position 1 (Figure 5D).
The 51 ends of these complementary small RNAs overlapped most frequently by 10 nt, which suggests
that these are vpiRNAs produced via the ‘ping-pong’ mechanism (Figure 5E). Taken together, this data
suggests that the antiviral RNAi response in TRA-171 cells is induced following SFV infection and
produces both vsiRNAs and vpiRNAs which target viral sequences.
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cells 24 h p.i. with SFV4 at MOI 10 followed by small RNA sequencing. (A) The size distribution of small
RNAs from SFV infected cells mapping to the SFV4 genome (red, positive numbers) or antigenome
(green, negative numbers). The distribution of 21 nt (B) or 28 nt (C) small RNAs across the length
of the SFV genome (red, positive numbers) or antigenome (green, negative numbers). The Y-axis
shows the frequency of small RNAs mapping to the corresponding nucleotide location on the X-axis.
(D) The conserved relative nucleotide frequency at each position of 29 nt long small RNAs mapping to
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represents the degree of sequence conservation. The level of conservation is indicated by the Y-axis.
(E) Frequency map showing the distance between the 51 ends of 25–29 nt small RNAs mapping to the
opposite strand of the SFV4 reference sequence. Position 0 represents the first nucleotide. The results
shown are representative of two independent experiments.
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Other analysis of the sequencing data revealed the presence of putative novel insect specific
viruses (ISVs), although further studies are needed to confirm their presence (Supplemental Materials
and Methods, Supplemental Table S3 and Figure S2). ISVs lack the ability to replicate in vertebrate cells
but have been naturally shown to infect a variety of arthropods in nature including mosquitoes and are
present in several mosquito derived cell lines [51–59]. It will be beneficial to assess their impact on the
host and their involvement in pathogen transmission in order to understand how this may affect vector
competence and arbovirus transmission within specific populations. How these ISVs, as well as other
sequences such as transposable elements (TEs) and endogenous viral elements (EVEs), interact with
the RNAi response will be important to develop a more complete awareness of the global role of RNAi
out with arboviral infections. For instance, given the known correlation between EVEs and the piRNA
pathway [60], this information may provide relevant data for understanding how viruses establish
a persistent infection and the potential for mosquitoes to pass on heritable immune indicators.
4. Discussion
Studies in mosquito vector species have shown that RNAi is the predominant antiviral response
against infections [17,19,20]. Specifically, the exo-siRNA has been demonstrated to be important in
regulating this antiviral activity, although the antiviral role of piRNAs is unclear. Previous research
has used D. melanogaster as a model for RNAi studies [61–69], but very few studies have investigated
the role of the RNAi pathways in non-vector mosquito species. Toxorhynchites is one of three mosquito
genera, along with Malaya and Topomyia, which do not require a blood meal during their adult life
stages to initiate egg development and, as such, do not exhibit host-seeking behavior [70,71]. Their lack
of importance as a medically relevant pest species has meant that their general biology has been largely
neglected. However, in their role as a biological control agent against pest species, Toxorhynchites may
be at risk of an arbovirus infection due to ingesting vertically infected larvae [15]. Therefore, it is
important to understand their antiviral capabilities.
This study identifies the presence of a functional RNAi response within Tx. amboinensis-derived
TRA-171 cells. SFV infection induced the production of 21 nt vsiRNAs derived from both
the viral genome and antigenome, which is indicative of Dcr2 cleavage of dsRNA [20].
A similar enrichment of 21 nt vsiRNAs has previously been reported for SFV, as well as other
alphaviruses [24,26,28,31,32,37,39,72] and members of the Bunyaviridae and Flaviviridae [18–21].
Deep sequencing of SFV-infected TRA-171 cells indicates that these vsiRNAs are distributed across
the genome and antigenome with hot spot and cold spot areas. This is consistent with previous
SFV data obtained from aedine cell lines [24,28,37,39]. Further work would be required to determine
whether vsiRNAs derived from cold spot regions are able to inhibit SFV replication significantly more
effectively than hot spot derived vsiRNAs, as has been shown previously [28].
In addition, larger classes of SFV-derived small RNAs between 24–29 nt were detected which
presented with the hallmark characteristic ping-pong motif of piRNAs; an A10/U1 bias and a 10 nt
overlap between the 51 ends of piRNAs from different strands, which has been previously described
in aedine cells [24,31,32,37]. Consistent with previous findings for SFV infection of Aag2 and U4.4
cells, these were less widely distributed and preferentially targeted specific regions of the coding
strand [24,31,32]. However, unlike data from aedine cells, these vpiRNAs are present in approximately
equal quantities against both sense and antisense sequences, rather than with a bias towards the sense
strand. The identification of 24–29 nt small RNAs displaying a A10 and U1 bias and a 10 nt overlap
between the 51 ends of different strands suggests that TRA-171 cells encode PIWI clade proteins.
Our findings show that the exo-siRNA pathway can be artificially induced in TRA-171 cells
by the transfection of long dsRNA molecules, which leads to sequence-specific silencing. Similarly,
our results also show that sequence-specific siRNAs are capable of achieving efficient gene silencing,
which supports the presence of a natural antiviral RNAi pathway within TRA-171 cells. Key mediator
proteins of the exo-siRNA pathway, such as Dcr2 and Ago2, are highly conserved between mosquito
and drosophila and the effector mechanisms are considered to be similar [73]. Previous studies have
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confirmed the importance of these proteins as mediators of infection as viral replication increases
following their knockdown [23,24,27,33,37,74]. Similarly, recent studies in Ae. aegypti show that Ago3,
Piwi5, and, to a lesser extent, Piwi6 participate in the production of viral-derived piRNAs [35,36].
Given the lack of genomic information available for Tx. amboinensis, it was not possible to identify
RNAi effector-encoding sequences and, therefore, we can only speculate if these proteins are present in
the Toxorhychites genome. However, the results presented here are a strong indicator for the presence of
RNAi machinery comparable to that of aedine species. Previous research has shown that arboviruses
are able to replicate to high levels within Toxorhynchites mosquitoes and their derived cell lines. The data
shown here for SFV replication and production is congruous with these findings. Further work will be
required to determine the exact temporal and spatial mechanisms, as well as the proteins involved in
the Toxorhynchites immune response, which permit enhanced arbovirus replication.
In conclusion, we have demonstrated the presence of an active antiviral RNAi response in
Toxorhynchites cells which successfully modulates SFV infection in a manner similar to that of natural
arboviral vector species. Only once we fully understand their ability to manage infections will we
be able to make an informed decision regarding the suitability of certain species as biological control
agents against vector mosquito species. Our data also expands on the current knowledge of ISVs,
TEs, and EVEs in mosquitoes that may influence pathogen transmission in vector populations and
highlights their interactions with the exo-siRNA and piRNA pathways.
Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4915/10/12/694/
s1, Supplemental Materials and Methods: Small RNA analysis for the identification of novel putative insect
specific viruses, Figure S1: Production of small RNAs from long dsRNA, Figure S2: Characteristics of contigs
derived from an EVE, TE, and a potential novel virus, Table S1: Primer sequences, Table S2: Sequencing reads
results, Table S3: Overview of assembled contigs showing similarity to viruses or TEs.
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